TVM Capital Life Science is a group of independent investment advisories and fund managers for Venture Capital funds, investing into innovative biotech, pharmaceutical, and medtech companies in Europe, Canada the USA and Asia, with teams based in Munich and Montreal.
Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Our investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. Our most recent Life Science Venture Capital Fund focuses on a new investment approach to developing pharmaceutical assets in a capital efficient fashion, to a human proof-of-concept in single asset companies.
TVM Capital Life Science operates with an integrated team from its offices in Montreal and Munich. Our mission is to invest in the development of exciting life science products and the growth of substantial companies in the field that are or aspire to be innovative leaders in their market segment.
Over several fund generations, our investment strategy has included a multi-stage investment approach spanning discovery to market ready companies as well as profitable companies searching for growth capital. Our investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. We invest in Canada, the U.S., Germany and Western Europe.
We are creating sustainable value – for patients, the pharmaceutical industry and our investors. Since 1984, TVM Capital Life Science has invested in more than 130 life science companies in Europe, Canada and the United States, currently managing in excess of €900 million from more than 50 investors.
TVM Capital GmbH
TVM Life Science Management GmbH
TVM Life Science Management Inc.
Montreal, Westmount, Canada